Rongxin Bio-Tech Co.,Ltd(H.K.)
FAX: 029-62388781
FEL: +8618220537895
E-mail: sales@rongxinbio.com
Address: Xi'an Jianshe Mansion,China, Shaanxi Sheng, Xian Shi, Yanta Qu, QuJiang ShangQuan, Yanta S Rd
Name:Letrazole 2.5mg
Presentation:2.5mg tablets, 100 tablet bottle
Purity:99%
Manufactured by:HEPLUS
Grade:Pharmaceutical Grade
Letrazole 2.5mg Tablets
Name | Letrazole 2.5mg |
Composition each tablet contains | Letrazole 2.5mg tables |
Presentation | 2.5mg tablets, 100 tablet bottle |
Supply ability | 100000/month |
Manufactured by | HEPLUS |
Purity | 99% |
Storage | Keep out of the reach of children; protect from light; store at room temperature; do not refrigerate or freeze |
Min order quantity | 5vials |
Shipping Method | EMS,DHL,UPS,TNT or FEDEX,HKEMS. |
Packing | As your require |
payment Method | Bank Transfer Bitcion |
Grade | Pharmaceutical Grade |
Usage | Pharmaceutical material, Steroid hormone, Anabolin. As a male hormone and anabolic hormones. |
Product Name: Letrozole Tablets
Main raw materials: The main ingredient of this product is: letrozole, its chemical name is: 1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole. Molecular formula: C17H11N5. Molecular weight: 285.31.
Letrozole, also known as Fury, is a white or off-white powder chemical. Chemical name 1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole; 4,4'-(1 H-1,2,4-triazol-1-ylidene Methyl)-bisbenzonitrile, molecular formula is C17H11N5, molecular weight is 285.31. It is a new generation of aromatase inhibitor, which is a synthetic benzyltriazole derivative. Letrozole reduces the level of estrogen by inhibiting aromatase, thereby eliminating the stimulating effect of estrogen on tumor growth. Endocrine therapy for breast cancer.
Main role: adjuvant therapy for postmenopausal women with early breast cancer who are positive for estrogen or progesterone receptors. Adjuvant therapy for postmenopausal women with early breast cancer who have received adjuvant tamoxifen for 5 years and are estrogen or progesterone receptor positive. Treatment of postmenopausal, estrogen receptor-positive, progesterone-receptor-positive, or undetermined advanced breast cancer patients, who should be in natural or artificially induced menopause.
Product Specifications: 2.5mg*100 Tablets
Dosage: The recommended dose of this product is 2.5 mg once a day.
Indications for letrozole
1. Letrozole is used in the treatment of postmenopausal advanced breast cancer (estrogen receptor, progesterone receptor positive or unknown receptor status), letrozole is mostly used for second-line treatment after the failure of anti-estrogen therapy;
2. Letrozole is used for the first-line treatment of locally advanced or spread postmenopausal breast cancer (foreign data);
3. Letrozole is used for extended adjuvant therapy of postmenopausal breast cancer patients who have received standard adjuvant therapy of tamoxifen for 5 years (Lerozole foreign data);
4. Letrozole is used for postoperative adjuvant therapy of hormone-positive early breast cancer patients.
Hong Kong Rongxin Biotech Co., Ltd. would provide you with high quality, high purity
Letrazole 2.5mg Tablets,Fast Shipping,And Best Services.
Contact information:
Enterprise mailbox:sell@rongxinbio.com
Skype:sell@rongxinbio.com
Whatsapp:+86-18789401944